FTC - Federal Trade Commission
09/20/2024 | Press release | Distributed by Public on 09/20/2024 10:02
Caremark Rx, Zinc Health Services, et al., In the Matter of (Insulin) - The FTC filed a lawsuit against the three largest prescription drug benefit managers (PBMs)—Caremark Rx,[...]
Tags:
Last Updated
September 20, 2024
Case Status
Pending
In the Matter of Caremark Rx, LLC; Zinc Health Services LLC; Express Scripts, Inc.; Evernorth Health, Inc.; Medco Health Services, Inc.; Ascent Health Services LLC; OptumRx, Inc.; OptumRx Holdings LLC; and Emisar Pharma Services LLC, Respondents
FTC Matter/File Number
221 0114
Docket Number
9437
Enforcement Type
Part 3 Administrative Complaints
Case Summary
The FTC filed a lawsuit against the three largest prescription drug benefit managers (PBMs)-Caremark Rx, Express Scripts (ESI), and OptumRx-and their affiliated group purchasing organizations (GPOs) for engaging in anticompetitive and unfair rebating practices that have artificially inflated the list price of insulin drugs.
Case Timeline
September 20, 2024